Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSorbic acid is an activator of hFFA2-DREADDs. Inhibits forskolin-induced cAMP production (IC50 ∼ 1 μM) and promotes accumulation of inositol monophosphates (IC50 >1 μM) in cells expressing hFFA2-DREADD. Promotes the release of GLP-1 from colonic crypts derived from hFFA2-DREADD-expressing mice.
M. Wt | 112.13 |
Formula | C6H8O2 |
Storage | Store at +4°C |
Purity | ≥98% (HPLC) |
CAS Number | 110-44-1 |
PubChem ID | 643460 |
InChI Key | WSWCOQWTEOXDQX-MQQKCMAXSA-N |
Smiles | CC=CC=CC(=O)O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Bolognini et al (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nat.Chem.Biol. 15 489 PMID: 30992568
Keywords: Sorbic acid, Sorbic acid supplier, free, fatty, acid, receptor, DREADD, agonists, agonism, designer, receptors, activated, by, drugs, chemogenetics, DREADDs, ligands, Free, Fatty, Acid, Receptors, 7119, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for Sorbic acid.
There are currently no reviews for this product. Be the first to review Sorbic acid and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Produced by Tocris, the chemogenetics research bulletin provides an introduction to chemogenetic methods to manipulate neuronal activity. It outlines the development of RASSLs, DREADDs and PSAMs, and the use of chemogenetic compounds. DREADD ligands and PSEMs available from Tocris are highlighted.
GPCRs can interact with multiple distinct transducers or regulatory proteins and these can be preferentially engaged in an agonist-specific manner giving rise to biased agonism. This poster discusses cutting edge GPCR signaling pharmacology and highlights therapeutic applications of biased agonism.